Clinical trial · Interventional
Fusion Versus Cognitive MRI Targeted Prostatic Biopsy
Magnetic Resonance Imaging Targeted (fusion) Versus Cognitive Prostatic Biopsy in Biopsy-naïve Suspected Cancer Prostate Patient a Comparison Study
NCT05969704CI-TRIAL-00085014completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study is to compare the accuracy of Magnetic resonance imaging targeted (fusion) versus cognitive prostatic biopsy in biopsy-naïve suspected cancer prostate patient
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI cognitive targeted prostatic biopsy | Procedure | — | UNRESOLVED |
| MRI fusion targeted prostatic biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- fusion biopsy
- description
- This biopsy procedure that combines the pictures from an MRI and an ultrasound to create a detailed 3-D image of the prostate. This procedure makes it easier to see an abnormal area of prostate in order to guide the biopsy needle into the abnormal area. A sample of tissue can then be taken and checked under a microscope for cancer. A fusion biopsy may help find prostate cancer cells that may be missed with other types of biopsies. It may help find cancer at an early stage and plan cancer treatment.
- interventionNames
- Procedure: MRI fusion targeted prostatic biopsy
- type
- ACTIVE_COMPARATOR
- label
- cognitive biopsy
- description
- the biopsy operator reviews the MR images and creates a mental three-dimensional representation of the prostate and of the lesion within it to take a biopsy from it
- interventionNames
- Procedure: MRI cognitive targeted prostatic biopsy
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * prostate biopsy-naïve men * PSA levels of up to 20 ng/mL * Multi-parametric prostate MRI revealed a PIRAD 4 or PIRAD 5. Exclusion Criteria: * PSA level greater than 20 ng/mL * patient with history of TRUS biopsy * patient diagnosed as cancer prostate or with distant metastasis
References
Publications (0)
Data not yet available
No reference posted for this study.